Entropy Technologies LP Invests $284,000 in The Allstate Co. (NYSE:ALL)

Entropy Technologies LP bought a new stake in shares of The Allstate Co. (NYSE:ALL) during the third quarter, HoldingsChannel.com reports. The institutional investor bought 1,500 shares of the insurance provider’s stock, valued at approximately $284,000.

Several other hedge funds also recently bought and sold shares of ALL. Allspring Global Investments Holdings LLC boosted its stake in shares of Allstate by 18.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after acquiring an additional 472,040 shares during the period. Raymond James & Associates grew its holdings in Allstate by 10.6% during the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after buying an additional 145,986 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Allstate by 3.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock valued at $229,545,000 after buying an additional 47,038 shares during the last quarter. Pathway Financial Advisers LLC lifted its holdings in shares of Allstate by 18,472.5% in the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after buying an additional 1,047,019 shares in the last quarter. Finally, Hsbc Holdings PLC boosted its position in shares of Allstate by 3.3% during the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock worth $160,948,000 after acquiring an additional 31,789 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Stock Up 0.6 %

Shares of NYSE:ALL opened at $196.88 on Friday. The firm has a market capitalization of $52.13 billion, a PE ratio of 12.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.48. The business has a 50 day simple moving average of $190.01 and a two-hundred day simple moving average of $176.72. The Allstate Co. has a 1 year low of $131.65 and a 1 year high of $201.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business’s revenue was up 14.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.81 earnings per share. On average, equities analysts predict that The Allstate Co. will post 16.07 EPS for the current year.

Allstate Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.87%. Allstate’s dividend payout ratio is currently 23.83%.

Analysts Set New Price Targets

A number of analysts have issued reports on ALL shares. Evercore ISI lifted their price target on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a report on Wednesday, October 9th. Jefferies Financial Group lifted their target price on Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a report on Friday, November 8th. TD Cowen raised their price target on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. JPMorgan Chase & Co. upped their price objective on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Finally, StockNews.com lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $214.19.

Insider Transactions at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. The trade was a 50.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 143,049 shares of company stock valued at $26,106,112. 1.80% of the stock is currently owned by company insiders.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.